FDA Approves New Antibiotic for Three Different Uses
The FDA approved a new antibiotic for the treatment of certain patients with Staphylococcus aureus bloodstream infections, including those with right-sided infective endocarditis; acute bacterial skin and skin structure infections; and community-acquired bacterial pneumonia.
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: FDA Source Type: news
More News: Bacterial Pneumonia | Drugs & Pharmacology | Endocarditis | Infective Endocarditis | Pneumonia | Skin | Staphylococcus Aureus